Back to Healthcare Services
    Healthcare Services

    Sell Your Dental Practice

    Dental practices are the most actively traded healthcare business in the US. The DSO consolidation wave has created a buyer market with 250+ active acquirers competing for well-run practices, and valuations that range from 5x EBITDA for owner-dependent single locations to 12x for multi-location groups with strong associate coverage and hygiene-driven revenue.

    FISART advises dental practice owners on sell-side processes designed for how DSOs, PE-backed groups, and institutional buyers underwrite dentistry. The difference between an average outcome and a premium exit is rarely about revenue growth. It is about hygiene contribution, patient retention, associate depth, and the ability to demonstrate that production survives the selling dentist's transition.

    Schedule a Free Consultation

    5-12x EBITDA

    250+ active buyers

    4-6 months

    Most active subsector

    Why Dental Practices Command Strong Buyer Interest

    Dental is the most active M&A subsector in all of healthcare, and the fundamentals explain why. Patient demand for dental care is recurring, largely non-discretionary, and resistant to economic downturns. Unlike many healthcare verticals, dental practices generate a significant portion of revenue from private pay and PPO insurance, which means higher reimbursement rates and less exposure to government payor risk than physician services or post-acute care.

    The DSO consolidation wave has been the defining force in dental M&A over the past decade. DSOs now account for roughly 15-20% of US dental practices, up from less than 5% in 2010. With more than $10B in PE capital committed to the sector, the pace of acquisitions continues to accelerate. For independent practice owners, this means a buyer market that is both deep and competitive.

    Hygiene revenue is the economic anchor that makes dental practices attractive to institutional capital. A well-run practice generates 30-40% of collections from hygiene services, which are recurring, high-margin, and delivered by staff who can be recruited and retained more reliably than dentists. Buyers underwrite hygiene contribution as the baseline cash flow that survives provider transitions, making it the single most important metric in dental valuation after adjusted EBITDA.

    The rollover equity model has also expanded the buyer pool. PE-backed DSOs typically offer sellers 70-85% cash at closing with 15-30% rollover into the platform. When the platform sells in 4-7 years, rolled equity can generate a second payout that exceeds the value of the initial equity contribution. This structure aligns seller and buyer incentives and has made PE-backed DSOs the most active and often highest-paying buyer category in the market.

    What Buyers Evaluate

    • Hygiene revenue as percentage of total collections
    • Patient retention rate and recall system effectiveness
    • Associate-to-owner production ratio
    • Chair utilization and scheduling density
    • Payor mix weighted toward private pay and PPO
    • Lease terms, facility condition, and equipment age

    Who Buys Dental Practices

    The dental buyer universe includes DSO platforms, PE-backed groups, family offices, and search funds. Each buyer type has distinct deal structures, post-close operating models, and valuation approaches. Matching your practice to the right buyer category is as important as the headline multiple.

    DSO platforms

    Dental Support Organizations like Heartland Dental, Aspen Dental, and Pacific Dental Services are the most active acquirers in dental M&A. They acquire practices to build regional and national networks, centralizing billing, marketing, HR, and supply chain while preserving clinical autonomy for dentists. Platform DSOs typically target practices with $1M+ EBITDA and offer rollover equity structures that allow sellers to participate in the platform's growth after closing.

    PE-backed dental groups

    Private equity sponsors have deployed billions into dental over the past decade, backing emerging DSO platforms and funding aggressive roll-up strategies. Firms like KKR (Heartland), Harvest Partners (Tend), and Leonard Green target both platform and add-on acquisitions. For practice owners, PE-backed groups often offer the highest upfront valuations because they are deploying committed capital within defined investment timelines.

    Family offices with dental investments

    Family offices are drawn to dental practices for the combination of recurring patient demand, high margins, and resistance to economic downturns. They typically invest with longer hold periods than PE firms, seek $1M-$8M EBITDA practices, and give owners more flexibility on post-close involvement. For dentists who want a clean exit without the pressure of PE-style growth targets, family office buyers are often the strongest fit.

    Search funds and independent sponsors

    Entrepreneurial acquirers backed by institutional capital target dental practices in the $500K-$3M EBITDA range that larger DSOs and PE groups pass over. They acquire with the intent to build a small multi-location platform over 5-7 years, adding locations through organic growth and acquisitions. For single-practice owners in this size range, search funds represent a motivated buyer category that values operational quality and location fundamentals.

    What Your Dental Practice Is Really Worth

    Dental practice valuations range from 5x to 12x EBITDA, with the spread driven by practice size, provider mix, hygiene contribution, and operational maturity. Single-location practices where the owner generates 70%+ of production typically trade at 5-8x EBITDA. Multi-location groups with associate coverage, consistent hygiene programs, and centralized operations trade at 8-12x. The DSO platform premium applies when a practice can serve as the anchor for a new geographic platform or fill a critical gap in an existing network.

    Compensation normalization is the most important adjustment in dental valuation. Buyers benchmark owner-dentist pay at 28-32% of collections for general dentistry, with variations by specialty. An owner collecting $2.5M who pays themselves $900K will see EBITDA adjusted downward by approximately $100K-$150K compared to market rates. Practices where owner compensation already aligns with DSO benchmarks preserve more of their headline EBITDA through buyer diligence.

    FISART builds a detailed practice analysis that segments your revenue by provider, quantifies hygiene contribution, measures patient retention and recall effectiveness, and benchmarks your compensation structure against DSO standards. The goal is presenting your practice so that buyers see validated, investable performance data from the first interaction, reducing the gap between initial offer and final closing value.

    Valuation Drivers

    • Hygiene revenue as percentage of total collections
    • Patient retention rate and recall system effectiveness
    • Associate-to-owner production ratio
    • Chair utilization and scheduling density
    • Payor mix weighted toward private pay and PPO
    • Lease terms, facility condition, and equipment age

    Which Segments Are in Highest Demand

    DSO acquisition activity spans all dental specialties, with general dentistry, orthodontics, and multi-location groups attracting the most competitive buyer interest in the current market.

    General dentistry practices
    Orthodontic practices
    Pediatric dental practices
    Oral surgery groups
    Multi-location dental groups
    Specialty dental (endodontics, periodontics)

    When Selling Makes Sense for You

    FISART works with dental practice owners who want a professionally managed, confidential transaction. Whether you are exploring a full sale, a DSO partnership, or a recapitalization with rollover equity, the starting point is understanding how dental buyers will evaluate your hygiene contribution, associate coverage, and patient retention today.

    We work with businesses that

    • You own a dental practice or group with $1M+ annual EBITDA
    • Your practice has established associate coverage or a defined recruitment pipeline
    • You are considering a full sale, DSO partnership, or growth capital raise
    • You have strong patient retention and a consistent hygiene program
    • You want to understand how DSO buyers will value your practice today

    Frequently Asked Questions

    Straight answers on valuation, deal structure, and process.

    Dental practice valuations range from 5x to 12x EBITDA depending on practice size, provider mix, and operational maturity. Single-location, owner-dependent practices typically trade at 5-8x EBITDA. Multi-location groups with associate coverage, strong hygiene revenue, and standardized operations trade at 8-12x. The key adjustment is owner compensation normalization: buyers benchmark owner-dentist pay at 28-32% of collections for general dentistry. If you collect $2M and pay yourself $800K, buyers will normalize your compensation closer to $600K and recalculate EBITDA accordingly. FISART prepares owners for these adjustments early so the final offer matches expectations.

    A Dental Support Organization (DSO) is a management company that handles the non-clinical operations of dental practices: billing, marketing, HR, supply chain, compliance, and facilities. Dentists retain clinical ownership and decision-making authority over patient care, while the DSO manages everything else. In a DSO acquisition, the buyer purchases the management company and enters a long-term management services agreement with the clinical entity. This structure preserves the dentist's professional autonomy while centralizing administrative functions that benefit from scale. DSOs range from large national platforms (Heartland, Aspen, Pacific Dental) with hundreds of locations to emerging regional groups building their first 10-20 offices.

    Clinical autonomy is the most common concern among dental sellers, and the answer depends heavily on which buyer you choose. Most DSOs are structured specifically to preserve clinical independence: the management services agreement defines the administrative functions the DSO controls, while treatment planning, case acceptance, and clinical protocols remain with the dentist. That said, some DSOs are more prescriptive than others about scheduling, production expectations, and approved materials. FISART runs processes that include multiple DSO and non-DSO buyers so owners can compare post-close operating models and choose the buyer whose approach to clinical governance aligns with their expectations.

    Rollover equity means reinvesting a portion of your sale proceeds (typically 15-30%) into the acquiring platform's parent company. You receive cash for the majority of the purchase price and equity in the combined entity for the remainder. The theory is that your rolled equity grows as the platform acquires additional practices and builds enterprise value. When the PE sponsor sells the platform in 4-7 years (the second bite), your rolled equity can be worth 2-4x its original value. Rollover is common in PE-backed dental transactions and can meaningfully increase total proceeds. FISART advises owners on evaluating rollover terms, platform growth trajectories, and the risk-reward profile of retaining equity exposure post-close.

    With proper preparation, most dental transactions close within 4-6 months from process launch. Dental deals tend to move faster than other healthcare verticals because diligence is more standardized and the buyer universe is deep. Preparation takes 2-4 weeks to normalize financials, document hygiene production, and assemble practice operations data. Buyer outreach and initial offers arrive within 5-7 weeks. Diligence through closing runs 8-12 weeks. Delays most often stem from lease assignment complications, associate recruitment gaps that surface during buyer meetings, or equipment condition issues discovered during site visits. FISART structures processes that address these risks before buyers encounter them.

    Associate management is critical to dental M&A outcomes. Buyers want to know that patient care and production will continue after the selling dentist reduces hours or exits. Practices with established associates who generate 40%+ of production demonstrate the transferability that commands premium pricing. For practices without associates, buyers will structure employment agreements for the selling dentist (typically 2-3 years), production-based earnouts, and a defined recruitment plan for associate coverage. FISART helps owners assess their associate bench, build credible transition plans, and position the practice's staffing model in a way that satisfies buyer underwriting requirements without requiring immediate associate hires before going to market.

    Talk to Us About Your Business

    A free initial analysis of your dental practice gives you clarity on valuation range, the most active buyer categories for your practice type, and the preparation steps that protect value through closing. No obligation, just a focused conversation about where you stand.

    Schedule a Free Consultation